PRESS RELEASE published on 06/18/2024 at 10:00, 1 year 5 months ago Advancing Kidney Care With Solidified Evidence – SphingoTec Presents PenKid at AKI & CRRT Course in Vicenza SphingoTec introduces kidney function biomarker PenKid at AKI & CRRT Course. PenKid addresses AKI diagnostic gaps with real-time assessment and risk prediction capabilities SphingoTec PenKid Kidney Function Biomarker AKI & CRRT Course Biomarker Integration
BRIEF published on 03/26/2024 at 13:05, 1 year 8 months ago SphingoTec annonce des changements majeurs dans sa direction Biomarqueurs Innovations Diagnostiques Changements De Gestion SphingoTec Soin Critique
BRIEF published on 03/26/2024 at 13:05, 1 year 8 months ago SphingoTec Announces Major Management Changes Biomarkers Management Changes Diagnostic Innovations SphingoTec Critical Care
PRESS RELEASE published on 03/26/2024 at 13:00, 1 year 8 months ago SphingoTec Announces Management Changes SphingoTec announces changes in management team with new appointments. Deborah Bergmann appointed as CEO. Dr. Florian Uhle as CMO and Nicole Witzmann as CFO. Company aims to enhance critical care diagnostics Management Team Biomarkers SphingoTec Deborah Bergmann Critical Care Diagnostics
PRESS RELEASE published on 10/05/2023 at 10:00, 2 years 2 months ago New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients
PRESS RELEASE published on 09/06/2023 at 10:00, 2 years 3 months ago International Experts Highlight Demand for Diagnostic Innovations as PenKid's Research and Real-World Data Fuels Quest for Improved RRT Liberation Tools
PRESS RELEASE published on 08/31/2023 at 12:30, 2 years 3 months ago Boditech Med and SphingoTec close Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid
PRESS RELEASE published on 05/09/2023 at 10:00, 2 years 7 months ago SphingoTec's Innovative IVD Product sphingotest® penKid® Receives First IVDR Certificate
PRESS RELEASE published on 04/04/2023 at 10:00, 2 years 8 months ago ADQI Group Recognizes PenKid as Relevant Functional Biomarker for Sepsis-Associated Acute Kidney Injury
PRESS RELEASE published on 02/23/2023 at 10:00, 2 years 9 months ago SphingoTec Appoints Dr. Florian Uhle as Medical Director
Published on 12/13/2025 at 02:00, 1 day 12 hours ago Battery X Metals Announces Confidential Submission of Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 12/13/2025 at 00:13, 1 day 14 hours ago Prospect Ridge Announces Non-Brokered Private Placement
Published on 12/12/2025 at 23:05, 1 day 15 hours ago ReelTime's RLTR Stock Surges Past AI Giants Following LG Smart TV Debut of Reel Intelligence
Published on 12/12/2025 at 17:00, 1 day 21 hours ago From Demonstration to Integration: How Sectors Actually Adopt SMX Technology
Published on 12/14/2025 at 14:10, 46 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 12/13/2025 at 19:57, 18 hours 59 minutes ago The Payments Group Holding identifies business activity fields and investment opportunities in AI company building and the biotech sector
Published on 12/13/2025 at 17:00, 21 hours 57 minutes ago Tapping into "Urban Oilfield": Unlocking the Value of Waste Plastic Film
Published on 12/13/2025 at 11:20, 1 day 3 hours ago Official streaming platform for the Games of the Future Abu Dhabi 2025 powered by ADNOC launches ahead of opening competition
Published on 12/13/2025 at 04:15, 1 day 10 hours ago M7 World Championship unveils first Opening Ceremony, tournament draw, and M7 Pass—elevates Indonesia on global stage
Published on 12/12/2025 at 18:00, 1 day 20 hours ago Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/12/2025 at 18:00, 1 day 20 hours ago Déclaration des transactions sur actions propres réalisées du 24 novembre au 28 novembre 2025
